A novel, simple approach to retrospective assessment of "blindability"
was applied to data on outpatients in a controlled, double-blind clinical
comparison of a putative antidepressant, etoperidone, and placebo. A
"blind" evaluator proved capable of discriminating between the active drug
and placebo on the basis of reported side effects alone, raising questions
about the true blindness of the study.Abstract Teaser